Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

AstraZeneca
Mallinckrodt
Moodys
McKesson
Express Scripts
Dow

Last Updated: August 19, 2022

Investigational Drug Information for D-glucose


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What is the development status for investigational drug D-glucose?

D-glucose is an investigational drug.

There have been 43 clinical trials for D-glucose. The most recent clinical trial was a Phase 2 trial, which was initiated on November 1st 2020.

The most common disease conditions in clinical trials are Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, and Carcinoma. The leading clinical trial sponsors are National Cancer Institute (NCI), M.D. Anderson Cancer Center, and University of Pennsylvania.

There are thirteen US patents protecting this investigational drug and six hundred and fifty-one international patents.

Recent Clinical Trials for D-glucose
TitleSponsorPhase
Split Course Adaptive Radiation Therapy With Pembrolizumab With/Without Chemotherapy for Treating Stage IV Lung CancerNational Cancer Institute (NCI)Phase 1/Phase 2
Split Course Adaptive Radiation Therapy With Pembrolizumab With/Without Chemotherapy for Treating Stage IV Lung CancerVarian Medical SystemsPhase 1/Phase 2
Split Course Adaptive Radiation Therapy With Pembrolizumab With/Without Chemotherapy for Treating Stage IV Lung CancerVanderbilt-Ingram Cancer CenterPhase 1/Phase 2

See all D-glucose clinical trials

Clinical Trial Summary for D-glucose

Top disease conditions for D-glucose
Top clinical trial sponsors for D-glucose

See all D-glucose clinical trials

US Patents for D-glucose

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
D-glucose See Plans and Pricing Cancerous B cell treatment using substituted nucleoside derivatives The Scripps Research Institute (La Jolla, CA) See Plans and Pricing
D-glucose See Plans and Pricing Adhesive base material Kowa Co., Ltd. (Nagoya, JP) See Plans and Pricing
D-glucose See Plans and Pricing Purified mite allergen Fumakilla Ltd. (Tokyo, JP) Hiroshima University (Hiroshima-Ken, JP) See Plans and Pricing
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Mallinckrodt
Moodys
McKesson
Express Scripts
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.